Tiziana Life Sciences, Ltd. has entered into a product development services agreement with Renaissance Lakewood LLC to enhance and scale up the formulation of its lead candidate, intranasal foralumab, ...
(MENAFN- GlobeNewsWire - Nasdaq) NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the“Company”), a biotechnology company developing breakthrough ...
NEW YORK, Feb. 21, 2025) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback